Loading clinical trials...
Loading clinical trials...
Among patients with SARS-CoV-2 pneumonia, approximately 20% have an acute kidney injury (AKI) and 5% require renal replacement therapy. Occurrence of AKI in patients with COVID-19 is associated with i...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Montpellier
NCT01306084 · Anogenital Herpes, COVID-19, and more
NCT07617948 · Acute Calculous Anuria, Ureteral Calculi, and more
NCT04551378 · COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, and more
NCT05218083 · COVID-19, Critical Illness, and more
NCT06369064 · Acute Kidney Injury, Continuous Renal Replacement Therapy, and more
Uhmontpellier
Montpellier
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions